Teva (TEVA) EVP Daniell Richard Sells 30,000 Shares

What Happened Daniell Richard, EVP, Europe Commercial at Teva Pharmaceutical Industries Ltd (TEVA), disposed of 30,000 shares on 2026-05-05. The Form 4 reports the sale at $35.40 per share for a total transaction value of $1,062,000. The filing lists the transaction as an open market or private sale (code S).

Key Details

• Transaction date and price: 2026-05-05 — 30,000 shares at $35.40 each.
• Total value: $1,062,000.
• Shares owned after transaction: Not disclosed in the filing.
• Footnote: F1 — Ordinary shares may be represented by American Depositary Shares (each ADS currently represents one Ordinary Share).
• Filing timeliness: Reported on Form 4 filed 2026-05-07; appears filed within the normal two‑business‑day window (timely).

Context This was a straight sale (disposition), not an option exercise or award. Sales by insiders can be routine (e.g., diversification, personal liquidity, or tax reasons) and do not by themselves indicate a change in the insider’s view of the company. Retail investors often watch for patterns of repeated insider buying or selling rather than a single sale.